Creating chimeras for organ transplants and how bats switch between their eyes and ears on the wing
Researchers have been making animal embryos from two different species, so-called “chimeras,” for years, by introducing stem cells from one species into a very early embryo of another species. The ultimate goal is to coax the foreign cells into forming an organ for transplantation. But questions abound: Can evolutionarily distant animals, like pigs and humans, be mixed togeth er to produce such organs? Or could species closely related to us, like chimps and macaques, stand in for tests with human cells? Staff Writer Kelly Servick joins host Sarah Crespi to discuss the research, the regulations, and the growing ethical ...
Source: Science Magazine Podcast - June 27, 2019 Category: Science Authors: Science Tags: Scientific Community Source Type: podcasts
Creating chimeras for organ transplants and how bats switch between their eyes and ears on the wing
Researchers have been making animal embryos from two different species, so-called “chimeras,” for years, by introducing stem cells from one species into a very early embryo of another species. The ultimate goal is to coax the foreign cells into forming an organ for transplantation. But questions abound: Can evolutionarily distant animals, like pigs and humans, be mixed together to produce such organs? Or could species closely related to us, like chimps and macaques, stand in for tests with human cells? Staff Writer Kelly Servick joins host Sarah Crespi to discuss the research, the regulations, and the growing ethical d...
Source: Science Magazine Podcast - June 27, 2019 Category: Science Authors: Science Magazine Source Type: podcasts
Creating chimeras for organ transplants and how bats switch between their eyes and ears on the wing
Researchers have been making animal embryos from two different species, so-called “chimeras,” for years, by introducing stem cells from one species into a very early embryo of another species. The ultimate goal is to coax the foreign cells into forming an organ for transplantation. But questions abound: Can evolutionarily distant animals, like pigs and humans, be mixed togeth er to produce such organs? Or could species closely related to us, like chimps and macaques, stand in for tests with human cells? Staff Writer Kelly Servick joins host Sarah Crespi to discuss the research, the regulations, and the growing ethical ...
Source: Science Magazine Podcast - June 27, 2019 Category: Science Authors: Science Tags: Scientific Community Source Type: podcasts
How to Manage MDS Patients who are Ineligible for Transplant
Daniel DeAngelo MD, Institute Physician, Professor of Medicine at Harvard Medical School comments on how myelodysplastic syndrome (MDS) patients who are ineligible for transplants can be managed. <br />
Author: obr
Added: 06/26/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 26, 2019 Category: Cancer & Oncology Source Type: podcasts
FDA Drug Safety Podcast: FDA warns about increased risk of cancer relapse with long-term use of azithromycin (Zithromax, Zmax) antibiotic after donor stem cell transplant
FDA Drug Safety podcast on azithromycin (Zithromax, Zmax) antibiotic (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - June 20, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: podcasts
Updates On The FORTE Trial: 3 Arm Study, Higher Amount Of Persistent MRD At One Year In Patients Who Received A Transplant
Philip McCarthy MD @plmcarthymd Of Roswell Park Comprehensive Cancer Center Discusses Updates On The FORTE Trial: 3 Arm Study, Higher Amount Of Persistent MRD At One Year In Patients Who Received A Tr...
Author: Annual-Meeting
Added: 06/13/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 14, 2019 Category: Cancer & Oncology Source Type: podcasts
Daratumumab Phase 3 Study: Phase 3 Randomized Study Of Daratumumab + Bortezomib:Thalidomide:Dexamethasone (D-VTd) VS VTd In Transplant-Eligible NDMM
Philippe Moreau, MD Of Nantes Faculty of Medicine Discusses Daratumumab Phase 3 Study: Phase 3 Randomized Study Of Daratumumab + Bortezomib:Thalidomide:Dexamet​hasone (D-VTd) VS VTd In Transplant-Eligi...
Author: Annual-Meeting
Added: 06/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 3, 2019 Category: Cancer & Oncology Source Type: podcasts
Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia
Charles Craddock MD PhD @charliecraddock of Queen Elizabeth Hospital discusses the Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell ...
Author: Annual-Meeting
Added: 05/31/2019 (Source: Oncology Tube)
Source: Oncology Tube - May 31, 2019 Category: Cancer & Oncology Source Type: podcasts
TWiV 548: Mice, shrews, and caterpillars
Vincent travels to the European Congress of Virology in Rotterdam and with local co-host Marion Koopmans speak with Martin Beer, Stephan Gunther, and Vera Ross about their careers and their work on Lassa virus, Borna virus, and insect viruses. Hosts: Vincent Racanielloand Marion Koopmans Guests: Martin Beer, Stephan Gunther, and Vera Ros Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode ECV2019 Partnerships not parachutes (TWiV 413) Fatal Borna disease virus infection in transplant recipients (NEJM) Sequencing of 2018 Lassa virus outbreak (Science) Zombie caterpil...
Source: This Week in Virology - MP3 Edition - May 19, 2019 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Sagar Lonial, MD, FACP - Innovative Therapeutic Concepts for ASCT-Eligible Patients With Myeloma: Advancing Toward More Effective Care Across Treatment Settings
Go online to PeerView.com/QAJ860 to view the entire program with slides. In this activity, based on a recent live symposium held at the 2019 Transplantation and Cellular Therapy Meetings of the American Society of Blood and Marrow Transplantation (ASBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR), experts in myeloma offer guidance on the selection and sequencing of innovative therapies for the ASCT-eligible patients with multiple myeloma, and address several ongoing clinical questions from the choice of novel induction and maintenance options to minimal residual disease monitoring and th...
Source: PeerView CME/CE Audio Podcast - Immunology - April 22, 2019 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
JAMA Facial Plastic Surgery : The Evolving Clinical Presentation of Acute Rejection in Facial Transplantation
Interview with Bohdan Pomahac, MD, author of The Evolving Clinical Presentation of Acute Rejection in Facial Transplantation (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - April 18, 2019 Category: General Medicine Source Type: podcasts
Tanya Siddiqi, MD - Harnessing Recent Advances in CAR-T Cell Therapy for Leukemia and Lymphoma in the Era of Stem Cell Transplantation
Go online to PeerView.com/ZGE860 to view the entire program with slides. In this activity, based on a recent live symposium held at the 2019 Transplantation and Cellular Therapy (TCT) Meetings in Houston, Texas, experts in hematology and oncology explore the science behind adoptive immunotherapy with chimeric antigen receptor (CAR)-T cells and discuss exciting new developments with this innovative approach as well as its clinical potential and role in managing relapsed/refractory hematologic malignancies, including in the context of hematopoietic stem cell transplantation (HCT). The expert panel also shares personal experi...
Source: PeerView CME/CE Audio Podcast - Immunology - April 15, 2019 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Alexander Perl, MD and James M. Foran, MD, FRCPC - Integrating Innovative Therapeutics With Allogeneic HCT in AML: Insights and Evidence From Induction to Maintenance
Go online to PeerView.com/PCE860 to view the entire program with slides. In this activity, based on a recent live symposium held at the 2019 TCT Meetings in Houston, Texas, experts in the management of AML illustrate the arrival of individualized care for HCT-eligible patients by profiling updated practice guidelines that support the use of novel agents across a range of clinical settings. The expert panelists also provide insights on the efficacy and safety evidence demonstrating that improved outcomes are possible when using cutting-edge targeted therapies, epigenetic modifiers, or antibodies in conjunction with transpla...
Source: PeerView CME/CE Audio Podcast - Immunology - April 8, 2019 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Madan H. Jagasia, MBBS, MS, MMHC - Innovative Therapies in Post-Transplant GVHD: Personal Insights From the Patient CaseBook
Go online to PeerView.com/XYM860 to view the entire program with slides. This activity utilizes a “CaseBook” format, offering learners a collection of patient case scenarios from the experts’ personal repertoire paired with analyses of how the treatment landscape in acute and chronic graft-versus-host disease (GVHD) is evolving. Hematology-oncology and bone marrow transplant professionals take a deep dive into the underlying immunology of GVHD and the latest evidence with innovative therapeutics while also obtaining expert perspectives on the practical application of these advancements as prophylaxis or for treatment...
Source: PeerView CME/CE Audio Podcast - Immunology - April 5, 2019 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
